Ares Capital Corp: Form 10-Q for the period ended Sep 30, 2020
Filed with the SEC on Oct 27, 2020 and accepted by EDGAR at Oct 26, 2020, 20:10 ET.
Management's discussion and analysis
As filed, 107,325 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The information contained in this section should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this Quarterly Report. In addition, some of the statements in this Quarterly Report (including in the following discussion) constitute forward- looking statements, which relate to future events or the future performance or financial condition of Ares Capital Corporation (the “Company,” “Ares Capital,” “we,” “us,” or “our”). The forward-looking statements contained in this report involve a number of risks and uncertainties, including statements concerning:
- our, or our portfolio companies’, future business, operations, operating results or prospects;
- the return or impact of current and future investments;
- the impact of global health epidemics, such as the current novel coronavirus (“COVID-19”) pandemic, on our or our portfolio companies’ business and the global economy;
- the impact of a protracted decline in the liquidity of credit markets on our business;
- the impact of the elimination of the London Interbank Offered Rate (“LIBOR”) on our operating results;
- the impact of fluctuations in interest rates on our business;
- the impact of changes in laws or regulations (including the interpretation thereof), including the Tax Cuts and Jobs Act and the Coronavirus Aid, Relief and Economic Security Act, governing our operations or the operations of our portfolio companies or the operations of our competitors;
- the expiration of the Securities and Exchange Commission’s (“the SEC”) exemptive order allowing co-investments with certain other funds managed by the investment adviser or its affiliates;
- the valuation of our investments in portfolio companies, particularly those having no liquid trading market;
- our ability to recover unrealized losses;
- market conditions and our ability to access alternative debt markets and additional debt and equity capital and our ability to manage our capital resources effectively;
- our contractual arrangements and relationships with third parties, including parties to our co-investment program;
- the general economy and its impact on the industries in which we invest;
- uncertainty surrounding the financial stability of the United States, Europe and China;
- the social, geopolitical, financial, trade and legal implications of Brexit;
- Middle East turmoil and the potential for volatility in energy prices and its impact on the industries in which we invest;
- the financial condition of our current and prospective portfolio companies and their ability to achieve their objectives;
- our expected financings and investments;
- our ability to successfully complete and integrate any acquisitions;
- the outcome and impact of any litigation;
- the adequacy of our cash resources and working capital;
- the timing, form and amount of any dividend distributions;
- the timing of cash flows, if any, from the operations of our portfolio companies; and
- the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments.
We use words such as “anticipates,” “believes,” “expects,” “intends,” “will,” “should,” “may” and similar expressions to identify forward-looking statements, although not all forward-looking statements include these words. Our actual results and condition could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in this Quarterly Report.
We have based the forward-looking statements included in this Quarterly Report on information available to us on the filing date of this Quarterly Report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we have filed or in the future may file with the SEC, including annual reports on Form 10-K, registration statements on Form N-2, quarterly reports on Form 10-Q and current reports on Form 8-K.
OVERVIEW
We are a specialty finance company that is a closed-end, non-diversified management investment company incorporated in Maryland. We have elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (together with the rules and regulations promulgated thereunder, the “Investment Company Act”).
We are externally managed by Ares Capital Management LLC (“Ares Capital Management” or our “investment adviser”), a subsidiary of Ares Management Corporation (NYSE: ARES) (“Ares Management”), a publicly traded, leading global alternative investment manager, pursuant to our investment advisory and management agreement. Ares Operations LLC (“Ares Operations” or our “administrator”), a subsidiary of Ares Management, provides certain administrative and other services necessary for us to operate.
Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in first lien senior secured loans (including “unitranche” loans, which are loans that combine both senior and mezzanine debt, generally in a first lien position), second lien senior secured loans and mezzanine debt, which in some cases includes an equity component like warrants.
To a lesser extent, we also make preferred and/or common equity investments, which have generally been non-control equity investments, of less than $20 million (usually in conjunction with a concurrent debt investment). However, we may increase the size or change the nature of these investments.
Since our initial public offering (“IPO”) on October 8, 2004 through September 30, 2020, our exited investments resulted in an asset level realized gross internal rate of return to us of approximately 14% (based on original cash invested, net of syndications, of approximately $29.1 billion and total proceeds from such exited investments of approximately $37.1 billion). Internal rate of return is the discount rate that makes the net present value of all cash flows related to a particular investment equal to zero. Internal rate of return is gross of expenses related to investments as these expenses are not allocable to specific investments. Investments are considered to be exited when the original investment objective has been achieved through the receipt of cash and/or non-cash consideration upon the repayment of a debt investment or sale of an investment or through the determination that no further consideration was collectible and, thus, a loss may have been realized. Approximately 59% of these exited investments resulted in an asset level realized gross internal rate of return to us of 10% or greater.
Additionally, since our IPO on October 8, 2004 through September 30, 2020, our realized gains have exceeded our realized losses by approximately $936 million (excluding a one time gain on the acquisition of Allied Capital Corporation (“Allied Capital”) in April 2010 (the “Allied Acquisition”) and realized gains/losses from the extinguishment of debt and other transactions). For this same time period, our average annualized net realized gain rate was approximately 1.1% (excluding a one-time gain on the acquisition of Allied Capital and realized gains/losses from the extinguishment of debt and other transactions). Net realized gain/loss rates for a particular period are the amount of net realized gains/losses during such period divided by the average quarterly investments at amortized cost in such period.
Information included herein regarding internal rates of return, realized gains and losses and annualized net realized gain rates are historical results relating to our past performance and are not necessarily indicative of future results, the achievement of which cannot be assured.
As a BDC, we are required to comply with certain regulatory requirements. For instance, we generally have to invest at least 70% of our total assets in “qualifying assets,” including securities and indebtedness of private U.S. companies and certain public U.S. companies, cash, cash equivalents, U.S. government securities and high-quality debt investments that mature in one year or less. We also may invest up to 30% of our portfolio in non-qualifying assets, as permitted by the Investment Company Act. Specifically, as part of this 30% basket, we may invest in entities that are not considered “eligible portfolio companies” (as defined in the Investment Company Act), including companies located outside of the United States, entities that are operating pursuant to certain exceptions under the Investment Company Act, and publicly traded entities whose public equity market capitalization exceeds the levels provided for under the Investment Company Act.
We have elected to be treated as a regulated investment company (“RIC”) under the Internal Revenue Code of 1986, as amended (the “Code”), and operate in a manner so as to qualify for the tax treatment applicable to RICs. To qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements and timely distribute to our stockholders generally at least 90% of our investment company taxable income, as defined by the Code, for each year. Pursuant to this election, we generally will not have to pay U.S. federal corporate-level taxes on any income that we distribute to our stockholders provided that we satisfy those requirements.
PORTFOLIO AND INVESTMENT ACTIVITY
Our investment activity for the three months ended September 30, 2020 and 2019 is presented below.
(dollar amounts in millions)
| New investment commitments(1): | For the Three Months Ended September 30, 2020 | 2019 |
|---|---|---|
| New portfolio companies | $414 | $1,274 |
| Existing portfolio companies | 292 | 1,135 |
| Total new investment commitments(2) | $706 | $2,409 |
| Less: | ||
| Investment commitments exited(3) | (352) | (1,424) |
| Net investment commitments | $354 | $985 |
| Principal amount of investments funded: | ||
| First lien senior secured loans(4) | $589 | $1,844 |
| Second lien senior secured loans | 1 | 199 |
| Subordinated certificates of the SDLP(5) | — | 1 |
| Senior subordinated loans | 1 | — |
| Preferred equity securities | 31 | 5 |
| Other equity securities | 10 | 49 |
| Total | $632 | $2,098 |
| Principal amount of investments sold or repaid: | ||
| First lien senior secured loans(4) | $332 | $937 |
| Second lien senior secured loans | 125 | 122 |
| Subordinated certificates of the SDLP(5) | 4 | 101 |
| Senior subordinated loans | 9 | 137 |
| Collateralized loan obligations | — | 1 |
| Preferred equity securities | 5 | 2 |
| Other equity securities | 6 | 10 |
| Total | $481 | $1,310 |
| Number of new investment commitments(6) | 24 | 50 |
| Average new investment commitment amount | $29 | $48 |
| Weighted average term for new investment commitments (in months) | 58 | 70 |
| Percentage of new investment commitments at floating rates | 90% | 96% |
| Percentage of new investment commitments at fixed rates | 7% | 2% |
| Weighted average yield of debt and other income producing securities(7): | ||
| Funded during the period at amortized cost | 8.1% | 8.5% |
| Funded during the period at fair value(8) | 8.2% | 8.6% |
| Exited or repaid during the period at amortized cost | 8.2% | 9.9% |
| Exited or repaid during the period at fair value(8) | 8.1% | 9.8% |
(1) New investment commitments include new agreements to fund revolving loans or delayed draw loans. See “Off Balance Sheet Arrangements” as well as Note 7 to our consolidated financial statements for the three and nine months ended September 30, 2020, for more information on our commitments to fund revolving loans or delayed draw loans.
(2) Includes both funded and unfunded commitments. Of these new investment commitments, we funded $0.4 billion and $1.8 billion, respectively, for the three months ended September 30, 2020 and 2019.
(3) Includes both funded and unfunded commitments. For the three months ended September 30, 2020 and 2019, investment commitments exited included exits of unfunded commitments of $39 million and $242 million, respectively.
(4) For the three months ended September 30, 2020, net repayments of first lien secured revolving loans were $153 million. For the three months ended September 30, 2019, net fundings of first lien secured revolving loans were $2 million.
(5) See “Senior Direct Lending Program” below and Note 4 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information on the SDLP (as defined below).
(6) Number of new investment commitments represents each commitment to a particular portfolio company or a commitment to multiple companies as part of an individual transaction (e.g., the purchase of a portfolio of investments).
(7) “Weighted average yield of debt and other income producing securities” is computed as (a) the annual stated interest rate or yield earned plus the net annual amortization of original issue discount and market discount or premium earned on accruing debt and other income producing securities, divided by (b) the total accruing debt and other income producing securities at amortized cost or at fair value, as applicable.
(8) Represents fair value for investments in the portfolio as of the most recent prior quarter end, if applicable.
As of September 30, 2020 and December 31, 2019, our investments consisted of the following:
(in millions)
| As of September 30, 2020 Amortized Cost | Fair Value(1) | December 31, 2019 Amortized Cost | Fair Value | |
|---|---|---|---|---|
| First lien senior secured loans(2) | $6,829 | $6,404 | $6,606 | $6,372 |
| Second lien senior secured loans | 4,271 | 4,017 | 4,439 | 4,334 |
| Subordinated certificates of the SDLP(3) | 929 | 929 | 909 | 909 |
| Senior subordinated loans | 1,053 | 1,021 | 815 | 822 |
| Collateralized loan obligations | 37 | 21 | 40 | 35 |
| Preferred equity securities | 881 | 749 | 815 | 728 |
| Other equity securities | 1,090 | 1,217 | 1,072 | 1,226 |
| Total | $15,090 | $14,358 | $14,696 | $14,426 |
(1) As of September 30, 2020, the fair value of our investments was negatively impacted by the uncertainty surrounding the impact of the COVID-19 pandemic. For more information, see “Results of Operations - Net Unrealized Gains/Losses.”
(2) First lien senior secured loans include certain loans that we classify as “unitranche” loans. The total amortized cost and fair value of the loans that we classified as “unitranche” loans were $2,165 million and $2,053 million, respectively, as of September 30, 2020, and $1,959 million and $1,885 million, respectively, as of December 31, 2019.
(3) The proceeds from these certificates were applied to co-investments with Varagon Capital Partners (“Varagon”) and its clients to fund first lien senior secured loans to 22 and 23 different borrowers as of September 30, 2020 and December 31, 2019, respectively.
The weighted average yields at amortized cost and fair value of the following portions of our portfolio as of September 30, 2020 and December 31, 2019 were as follows:
| As of September 30, 2020 Amortized Cost | Fair Value | December 31, 2019 Amortized Cost | Fair Value | |
|---|---|---|---|---|
| Debt and other income producing securities(1) | 9.1% | 9.4% | 9.6% | 9.7% |
| Total portfolio(2) | 7.8% | 8.2% | 8.6% | 8.7% |
| First lien senior secured loans(2) | 7.5% | 8.0% | 7.7% | 7.9% |
| Second lien senior secured loans(2) | 8.7% | 9.2% | 10.2% | 10.4% |
| Subordinated certificates of the SDLP(2)(3) | 13.3% | 13.3% | 14.5% | 14.5% |
| Senior subordinated loans(2) | 9.2% | 9.5% | 11.4% | 11.3% |
| Collateralized loan obligations | 12.6% | 22.1% | 16.9% | 18.9% |
| Income producing equity securities(2) | 11.5% | 11.3% | 12.5% | 12.3% |
(1) “Weighted average yield of debt and other income producing securities” is computed as (a) the annual stated interest rate or yield earned plus the net annual amortization of original issue discount and market discount or premium earned on accruing debt and other income producing securities, divided by (b) the total accruing debt and other income producing securities at amortized cost or at fair value as applicable.
(2) “Weighted average yields” are computed as (a) the annual stated interest rate or yield earned plus the net annual amortization of original issue discount and market discount or premium earned on the relevant accruing debt and other income producing securities, divided by (b) the total relevant investments at amortized cost or at fair value as applicable.
(3) The proceeds from these certificates were applied to co-investments with Varagon and its clients to fund first lien senior secured loans.
Ares Capital Management, our investment adviser, employs an investment rating system to categorize our investments. In addition to various risk management and monitoring tools, our investment adviser grades the credit risk of all investments on a scale of 1 to 4 no less frequently than quarterly. This system is intended primarily to reflect the underlying risk of a portfolio investment relative to our initial cost basis in respect of such portfolio investment (i.e., at the time of origination or acquisition), although it may also take into account under certain circumstances the performance of the portfolio company’s business, the collateral coverage of the investment and other relevant factors. Under this system, investments with a grade of 4 involve the least amount of risk to our initial cost basis. The trends and risk factors for this investment since origination or acquisition are generally favorable, which may include the performance of the portfolio company or a potential exit. Investments graded 3 involve a level of risk to our initial cost basis that is similar to the risk to our initial cost basis at the time of origination or acquisition. This portfolio company is generally performing as expected and the risk factors to our ability to ultimately recoup the cost of our investment are neutral to favorable. All investments or acquired investments in new portfolio companies are initially assessed a grade of 3. Investments graded 2 indicate that the risk to our ability to recoup the initial cost basis of such investment has increased materially since origination or acquisition, including as a result of factors such as declining performance and non-compliance with debt covenants; however, payments are generally not more than 120 days past due. An investment grade of 1 indicates that the risk to our ability to recoup the initial cost basis of such investment has substantially increased since origination or acquisition, and the portfolio company likely has materially declining performance. For debt investments with an investment grade of 1, most or all of the debt covenants are out of compliance and payments are substantially delinquent. For investments graded 1, it is anticipated that we will not recoup our initial cost basis and may realize a substantial loss of our initial cost basis upon exit. For investments graded 1 or 2, our investment adviser enhances its level of scrutiny over the monitoring of such portfolio company. The grade of a portfolio investment may be reduced or increased over time.
Set forth below is the grade distribution of our portfolio companies as of September 30, 2020 and December 31, 2019:
(dollar amounts in millions)
| As of September 30, 2020 Fair Value% | Number of Companies% | December 31, 2019 Fair Value% | Number of Companies% | |||||
|---|---|---|---|---|---|---|---|---|
| Grade 1 | $220 | 1.5% | 27 | 7.8% | $92 | 0.6% | 19 | 5.4% |
| Grade 2 | 2,596 | 18.1% | 56 | 16.1% | 688 | 4.8% | 14 | 4.0% |
| Grade 3 | 10,049 | 70.0% | 230 | 66.3% | 12,407 | 86.0% | 301 | 85.0% |
| Grade 4 | 1,493 | 10.4% | 34 | 9.8% | 1,239 | 8.6% | 20 | 5.6% |
| Total | $14,358 | 100.0% | 347 | 100.0% | $14,426 | 100.0% | 354 | 100.0% |
As of September 30, 2020 and December 31, 2019, the weighted average grade of the investments in our portfolio at fair value was 2.9 and 3.0, respectively. As of September 30, 2020, there was an increase in investments graded 1 and 2 and a resulting decline in the investments graded 3 as compared to as of December 31, 2019, primarily due to our view of the increased risk around our ability to recoup the initial cost basis of such investments given the duration of the COVID-19 pandemic so far and the continuing uncertainty surrounding its full duration and impact. For more information, see “Results of Operations - Net Unrealized Gains/Losses.”
As of September 30, 2020, loans on non-accrual status represented 5.1% and 3.2% of the total investments at amortized cost and at fair value, respectively. As of December 31, 2019, loans on non-accrual status represented 1.9% and 0.9% of the total investments at amortized cost and at fair value, respectively.
Senior Direct Lending Program
We have established a joint venture with Varagon to make certain first lien senior secured loans, including certain stretch senior and unitranche loans, primarily to U.S. middle-market companies. Varagon was formed in 2013 as a lending platform by American International Group, Inc. and other partners. The joint venture is called the Senior Direct Lending Program, LLC (d/b/a the “Senior Direct Lending Program” or the “SDLP”). In July 2016, we and Varagon and its clients completed the initial funding of the SDLP. The SDLP may generally commit and hold individual loans of up to $350 million. The SDLP is capitalized as transactions are completed and all portfolio decisions and generally all other decisions in respect of the SDLP must be approved by an investment committee of the SDLP consisting of representatives of ours and Varagon (with approval from a representative of each required).
We provide capital to the SDLP in the form of subordinated certificates (the “SDLP Certificates”), and Varagon and its clients provide capital to the SDLP in the form of senior notes, intermediate funding notes and SDLP Certificates. As of September 30, 2020, we and a client of Varagon owned 87.5% and 12.5%, respectively, of the outstanding SDLP Certificates.
As of September 30, 2020 and December 31, 2019, we and Varagon and its clients had agreed to make capital available to the SDLP of $6.2 billion and $6.2 billion, respectively, in the aggregate, of which $1.4 billion and $1.4 billion, respectively, is to be made available from us. This capital will only be committed to the SDLP upon approval of transactions by the investment committee of the SDLP. Below is a summary of the funded capital and unfunded capital commitments of the SDLP.
(in millions)
| As of September 30, 2020 | December 31, 2019 | |
|---|---|---|
| Total capital funded to the SDLP(1) | $3,911 | $3,899 |
| Total capital funded to the SDLP by the Company(1) | $929 | $909 |
| Total unfunded capital commitments to the SDLP(2) | $274 | $404 |
| Total unfunded capital commitments to the SDLP by the Company(2) | $67 | $94 |
(1) At principal amount.
(2) These commitments to fund delayed draw loans have been approved by the investment committee of the SDLP and will be funded if and when conditions to funding such delayed draw loans are met.
The SDLP Certificates pay a coupon equal to LIBOR plus 8.0% and also entitle the holders thereof to receive a portion of the excess cash flow from the loan portfolio, after expenses, which may result in a return to the holders of the SDLP Certificates that is greater than the stated coupon. The SDLP Certificates are junior in right of payment to the senior notes and intermediate funding notes.
The amortized cost and fair value of our SDLP Certificates were $929 million and $929 million, respectively, as of September 30, 2020 and $909 million and $909 million, respectively, as of December 31, 2019. Our yield on our investment in the SDLP Certificates at amortized cost and fair value was 13.3% and 13.3%, respectively, as of September 30, 2020 and 14.5% and 14.5%, respectively, as of December 31, 2019. For the three and nine months ended September 30, 2020, we earned interest income of $32 million and $92 million, respectively, from our investment in the SDLP Certificates. For the three and nine months ended September 30, 2019, we earned interest income of $32 million and $91 million, respectively, from our investment in the SDLP Certificates. We are also entitled to certain fees in connection with the SDLP. For the three and nine months ended September 30, 2020, in connection with the SDLP, we earned capital structuring service and other fees totaling $1 million and $3 million, respectively. For the three and nine months ended September 30, 2019, we earned capital structuring service and other fees totaling $2 million and $17 million, respectively.
As of September 30, 2020 and December 31, 2019, the SDLP’s portfolio was comprised entirely of first lien senior secured loans primarily to U.S. middle-market companies and were in industries similar to the companies in our portfolio. As of September 30, 2020 and December 31, 2019, none of the loans were on non-accrual status. Below is a summary of the SDLP’s portfolio:
(dollar amounts in millions)
| As of September 30, 2020 | December 31, 2019 | |
|---|---|---|
| Total first lien senior secured loans(1)(2) | $3,917 | $3,892 |
| Weighted average yield on first lien senior secured loans(3) | 7.0% | 7.7% |
| Largest loan to a single borrower(1) | $346 | $348 |
| Total of five largest loans to borrowers(1) | $1,460 | $1,391 |
| Number of borrowers in the SDLP | 22 | 23 |
| Commitments to fund delayed draw loans (4) | $274 | $404 |
(1) At principal amount.
(2) First lien senior secured loans include certain loans that the SDLP classifies as “unitranche” loans. As of September 30, 2020 and December 31, 2019, the total principal amount of loans in the SDLP portfolio that the SDLP classified as “unitranche” loans was $3,664 million and $3,643 million, respectively.
(3) Computed as (a) the annual stated interest rate on accruing first lien senior secured loans, divided by (b) total first lien senior secured loans at principal amount.
(4) As discussed above, these commitments have been approved by the investment committee of the SDLP.
Selected financial information for the SDLP as of September 30, 2020 and December 31, 2019 and for the nine months ended September 30, 2020 and 2019, was as follows:
(in millions)
| Selected Balance Sheet Information: | As of September 30, 2020 | December 31, 2019 |
|---|---|---|
| Investments at fair value (amortized cost of $3,917 and $3,892, respectively) | $3,763 | $3,817 |
| Other assets | 90 | 91 |
| Total assets | $3,853 | $3,908 |
| Senior notes | $2,757 | $2,769 |
| Intermediate funding notes | 92 | 92 |
| Other liabilities | 64 | 63 |
| Total liabilities | 2,913 | 2,924 |
| Subordinated certificates and members’ capital | 940 | 984 |
| Total liabilities and members’ capital | $3,853 | $3,908 |
(in millions)
| Selected Statement of Operations Information: | For the Nine Months Ended September 30, 2020 | 2019 |
|---|---|---|
| Total interest and other income | $226 | $217 |
| Interest expense | 89 | 103 |
| Other expenses | 12 | 10 |
| Total expenses | 101 | 113 |
| Net investment income | 125 | 104 |
| Net realized and unrealized losses on investments | (92) | (33) |
| Net increase in members’ capital resulting from operations | $33 | $71 |
133
SDLP Loan Portfolio as of September 30, 2020
| (dollar amounts in millions) Portfolio Company | Business Description | Maturity Date | Stated Interest Rate(1) | Principal Amount | Fair Value(2) |
|---|---|---|---|---|---|
| 42 North Dental, LLC (3) | Dental services provider | 5/2022 | 7.3% | $160.1 | $150.5 |
| ADCS Clinics Intermediate Holdings, LLC (3) | Dermatology practice | 5/2022 | 6.8% | 77.2 | 74.1 |
| AEP Holdings, Inc. (3)(4) | Distributor of non-discretionary, mission-critical aftermarket replacement parts | 8/2021 | 7.0% | 157.1 | 157.1 |
| BakeMark Holdings, Inc. | Manufacturer and distributor of specialty bakery ingredients | 8/2023 | 6.3% | 243.4 | 240.9 |
| Center for Autism and Related Disorders, LLC (3) | Autism treatment and services provider specializing in applied behavior analysis therapy | 11/2024 | 5.5% | 123.3 | 114.7 |
| Chariot Acquisition, LLC (3) | Manufacturer of aftermarket golf cart parts and accessories | 9/2021 | 7.5% | 97.9 | 97.9 |
| D4C Dental Brands, Inc. (3)(4) | Dental services provider | 12/2022 | 8.3% | 187.9 | 180.3 |
| Emergency Communications Network, LLC (3) | Provider of mission critical emergency mass notification solutions | 6/2023 | 8.8% | 218.0 | 194.0 |
| Entertainment Partners Canada ULC (3)(4) | Provider of entertainment workforce and production management solutions | 5/2026 | 6.0% | 345.6 | 324.9 |
| Excelligence Learning Corporation (3) | Developer, manufacturer and retailer of educational products | 4/2023 | 8.0% | 147.9 | 119.8 |
| FS Squared Holding Corp. (3)(4) | Provider of on-site vending and micro-market solutions to employers | 3/2025 | 5.4% | 180.3 | 167.7 |
| Infogix, Inc. (3)(4) | Enterprise data analytics and integrity software solutions provider | 4/2024 | 8.0% | 124.6 | 124.6 |
| KeyImpact Holdings, Inc. (4) | Foodservice sales and marketing agency | 1/2022 | 8.9% | 73.6 | 73.6 |
| n2y Holding, LLC (3) | Developer of cloud-based special education platform | 11/2026 | 7.0% | 130.3 | 130.3 |
| Nordco Inc. (3) | Manufacturer of railroad maintenance-of-way machinery | 12/2022 | 9.5% | 106.2 | 105.2 |
| Pegasus Global Enterprise Holdings, LLC (3)(4) | Provider of plant maintenance and scheduling software | 5/2025 | 6.8% | 346.2 | 339.3 |
| Penn Detroit Diesel Allison, LLC | Distributor of aftermarket parts to the heavy-duty truck industry | 12/2021 | 7.3% | 71.9 | 71.2 |
| SM Wellness Holdings, Inc. (3)(4) | Breast cancer screening provider | 8/2024 | 6.5% | 244.8 | 235.0 |
| TDG Group Holding Company(3)(4) | Operator of multiple franchise concepts primarily related to home maintenance or repairs | 5/2024 | 5.4% | 244.5 | 244.5 |
| THG Acquisition, LLC (3) | Multi-line insurance broker | 12/2026 | 6.8% | 228.4 | 228.4 |
| Towne Holdings, Inc. | Parking management and hospitality services provider | 5/2022 | 9.8% | 129.3 | 109.9 |
| Woodstream Group, Inc. (3) | Manufacturer of natural solution pest and animal control products | 5/2022 | 7.3% | 278.7 | 278.7 |
| $3,917.2 | $3,762.6 |
(1) Represents the weighted average annual stated interest rate as of September 30, 2020. All stated interest rates are payable in cash, except for portions of the stated interest rates which are payment-in-kind for investments in D4C Dental Brands, Inc., Emergency Communications Network, LLC, Excelligence Learning Corporation, KeyImpact Holdings, Inc., Nordco Inc. and Towne Holdings, Inc.
(2) Represents the fair value in accordance with Accounting Standards Codification 820-10, *Fair Value Measurements and Disclosures (“*ASC 820-10”). The determination of such fair value is not included in our board of directors valuation process described elsewhere herein.
(3) We also hold a portion of this company’s first lien senior secured loan.
(4) We hold an equity investment in this company.
SDLP Loan Portfolio as of December 31, 2019
| (dollar amounts in millions) Portfolio Company | Business Description | Maturity Date | Stated Interest Rate(1) | Principal Amount | Fair Value(2) |
|---|---|---|---|---|---|
| 42 North Dental, LLC (3) | Dental services provider | 5/2022 | 7.9% | $152.3 | $152.3 |
| ADCS Clinics Intermediate Holdings, LLC (3) | Dermatology practice | 5/2022 | 7.7% | 77.8 | 77.0 |
| AEP Holdings, Inc. (3)(4) | Distributor of non-discretionary, mission-critical aftermarket replacement parts | 8/2021 | 7.9% | 158.3 | 150.4 |
| BakeMark Holdings, Inc. | Manufacturer and distributor of specialty bakery ingredients | 8/2023 | 7.2% | 245.3 | 245.3 |
| Center for Autism and Related Disorders, LLC (3) | Autism treatment and services provider specializing in applied behavior analysis therapy | 11/2024 | 5.9% | 117.8 | 117.8 |
| Chariot Acquisition, LLC (3) | Manufacturer of aftermarket golf cart parts and accessories | 9/2021 | 8.4% | 99.7 | 98.7 |
| D4C Dental Brands, Inc. (3)(4) | Dental services provider | 12/2022 | 8.2% | 179.9 | 179.9 |
| Emergency Communications Network, LLC (3) | Provider of mission critical emergency mass notification solutions | 6/2023 | 8.2% | 219.2 | 190.7 |
| Entertainment Partners Canada ULC (3)(4) | Provider of entertainment workforce and production management solutions | 5/2026 | 7.7% | 348.1 | 348.1 |
| Excelligence Learning Corporation (3) | Developer, manufacturer and retailer of educational products | 4/2023 | 7.9% | 145.0 | 118.9 |
| FS Squared Holding Corp. (3)(4) | Provider of on-site vending and micro-market solutions to employers | 3/2025 | 7.2% | 181.7 | 181.7 |
| Infogix, Inc. (3)(4) | Enterprise data analytics and integrity software solutions provider | 4/2024 | 8.4% | 125.5 | 125.5 |
| ISS Compressors Industries, Inc. | Provider of repairs, refurbishments and services to the broader industrial end user markets | 6/2020 | 8.9% | 80.2 | 79.4 |
| KeyImpact Holdings, Inc. (4) | Foodservice sales and marketing agency | 11/2021 | 8.0% | 74.0 | 74.0 |
| n2y Holding, LLC (3) | Developer of cloud-based special education platform | 11/2026 | 7.9% | 131.3 | 129.9 |
| Nordco Inc. (3) | Manufacturer of railroad maintenance-of-way machinery | 8/2020 | 8.4% | 110.1 | 106.8 |
| Pegasus Global Enterprise Holdings, LLC (3)(4) | Provider of plant maintenance and scheduling software | 5/2025 | 7.7% | 270.1 | 267.5 |
| Penn Detroit Diesel Allison, LLC | Distributor of aftermarket parts to the heavy-duty truck industry | 12/2021 | 8.2% | 77.6 | 77.6 |
| SM Wellness Holdings, Inc. (3)(4) | Breast cancer screening provider | 8/2024 | 7.4% | 226.6 | 226.6 |
| TDG Group Holding Company (3)(4) | Operator of multiple franchise concepts primarily related to home maintenance or repairs | 5/2024 | 7.4% | 246.3 | 246.3 |
| THG Acquisition, LLC (3) | Multi-line insurance broker | 12/2026 | 7.7% | 214.8 | 212.6 |
| Towne Holdings, Inc. | Parking management and hospitality services provider | 5/2022 | 7.2% | 130.0 | 128.7 |
| Woodstream Group, Inc. (3) | Manufacturer of natural solution pest and animal control products | 5/2022 | 8.2% | 280.8 | 280.8 |
| $3,892.4 | $3,816.5 |
(1) Represents the weighted average annual stated interest rate as of December 31, 2019. All stated interest rates are payable in cash.
(2) Represents the fair value in accordance with ASC 820-10. The determination of such fair value is not included in our board of directors valuation process described elsewhere herein.
(3) We also hold a portion of this company’s first lien senior secured loan.
(4) We hold an equity investment in this company.
RESULTS OF OPERATIONS
For the three and nine months ended September 30, 2020 and 2019
Operating results for the three and nine months ended September 30, 2020 and 2019 were as follows:
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Total investment income | $352 | $387 | $1,071 | $1,142 |
| Total expenses, net of waiver of income based fees | 182 | 170 | 494 | 508 |
| Net investment income before income taxes | 170 | 217 | 577 | 634 |
| Income tax expense, including excise tax | 4 | 5 | 12 | 13 |
| Net investment income | 166 | 212 | 565 | 621 |
| Net realized gains (losses) on investments, foreign currency and other transactions | (25) | (63) | 17 | 14 |
| Net unrealized gains (losses) on investments, foreign currency and other transactions | 300 | 26 | (476) | (46) |
| Net increase in stockholders’ equity resulting from operations | $441 | $175 | $106 | $589 |
Net income can vary substantially from period to period due to various factors, including acquisitions, the level of new investment commitments, the recognition of realized gains and losses and unrealized appreciation and depreciation. As a result, comparisons of net increase in stockholders’ equity resulting from operations may not be meaningful.
Investment Income
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Interest income from investments | $280 | $299 | $865 | $884 |
| Capital structuring service fees | 12 | 41 | 56 | 124 |
| Dividend income | 37 | 39 | 109 | 108 |
| Other income | 23 | 8 | 41 | 26 |
| Total investment income | $352 | $387 | $1,071 | $1,142 |
Interest income from investments for the three and nine months ended September 30, 2020 decreased from the comparable periods in 2019 primarily as a result of the decrease in the weighted average yield of our portfolio partially offset against an increase in the average size of our portfolio. The decline in the weighted average yields for the three and nine months ended September 30, 2020, as compared to the same periods in 2019 were primarily due to the decline in LIBOR. The average size and weighted average yield of our portfolio at amortized cost for the three and nine months ended September 30, 2020 and 2019 were as follows:
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Average size of portfolio | $14,976 | $13,827 | $15,082 | $13,447 |
| Weighted average yield on portfolio | 7.9% | 9.1% | 8.1% | 9.3% |
The decrease in capital structuring service fees for the three and nine months ended September 30, 2020 from the comparable periods in 2019 was primarily due to the decrease in new investment commitments. This decline was further impacted by the decrease in the weighted average capital structuring service fees. During the three and nine months ended September 30, 2019, we experienced higher fee opportunities as compared to the comparable periods in 2020 primarily due to a higher number of transactions with larger portfolio companies in larger issuances. The volatility and disruption to the global economy and capital markets from the COVID-19 pandemic has reduced the pace of our investment activity. For additional information concerning the COVID-19 pandemic and its potential impact on our business and our operating results, see Part II - Other information, Item 1A. Risk Factors, “Risk Factors - The COVID-19 pandemic has caused severe disruptions in the global economy, which has had, and may continue to have, a negative impact on our portfolio companies and our business and operations.” The new investment commitments and weighted average capital structuring service fee percentages for the three and nine months ended September 30, 2020 and 2019 were as follows:
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| New investment commitments | $706 | $2,409 | $2,836 | $5,668 |
| Weighted average capital structuring service fee percentages | 1.8% | 1.7% | 2.0% | 2.2% |
Dividend income for the three and nine months ended September 30, 2020 and 2019 were as follows:
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Dividend income received from IHAM | $19 | $18 | $54 | $50 |
| Recurring dividends | 17 | 18 | 53 | 51 |
| Non-recurring dividends | 1 | 3 | 2 | 7 |
| Total dividend income | $37 | $39 | $109 | $108 |
Other income for the three and nine months ended September 30, 2020 increased from the comparable periods in 2019 primarily due to an increase in amendment and other fees.
Operating Expenses
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Interest and credit facility fees | $77 | $76 | $235 | $212 |
| Base management fees | 53 | 52 | 161 | 151 |
| Income based fees | 42 | 49 | 127 | 146 |
| Capital gains incentive fees(1) | — | (8) | (58) | (7) |
| Administrative fees | 3 | 4 | 10 | 11 |
| Other general and administrative | 7 | 7 | 19 | 25 |
| Total expenses | 182 | 180 | 494 | 538 |
| Waiver of income based fees | — | (10) | — | (30) |
| Total expenses, net of waiver of income based fees | $182 | $170 | $494 | $508 |
(1) Calculated in accordance with U.S. generally accepted accounting principles (”GAAP”) as discussed below.
Interest and credit facility fees for the three and nine months ended September 30, 2020 and 2019 were comprised of the following:
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Stated interest expense | $64 | $65 | $203 | $185 |
| Credit facility fees | 4 | 4 | 10 | 8 |
| Amortization of debt issuance costs | 7 | 5 | 16 | 13 |
| Net accretion of discount on notes payable | 2 | 2 | 6 | 6 |
| Total interest and credit facility fees | $77 | $76 | $235 | $212 |
Stated interest expense for the three months ended September 30, 2020 remained steady from the comparable period in 2019 as the decline in LIBOR was offset by an increase in the average principal amount of debt outstanding. Stated interest expense for the nine months ended September 30, 2020 increased from the comparable period in 2019 primarily due to the increase in the average principal amount of debt outstanding. Effective June 21, 2019, our asset coverage requirement applicable to senior securities was reduced from 200% to 150%. Our debt to equity ratio increased to 1.10x as of September 30, 2020 from 0.91x as of September 30, 2019, primarily as a result of an increase in the total debt outstanding which increased our interest expense. The decrease in our weighted average stated interest rate for the three and nine months ended September 30, 2020 from the comparable periods in 2019 was primarily due to the decline in LIBOR, which lowered the stated interest rate on our revolving credit facilities. Average debt outstanding and weighted average stated interest rate on our debt outstanding for the three and nine months ended September 30, 2020 and 2019 were as follows:
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Average debt outstanding | $7,495 | $6,387 | $7,635 | $5,989 |
| Weighted average stated interest rate on debt | 3.5% | 4.2% | 3.5% | 4.1% |
Credit facility fees for the nine months ended September 30, 2020 were higher from the comparable period in 2019 primarily due to increased borrowing capacities in our revolving facilities resulting in higher unused commitment fees.
The increase in base management fees for the three and nine months ended September 30, 2020 from the comparable periods in 2019 was primarily due to the increase in the average size of our portfolio for the three and nine months ended September 30, 2020 as compared to the comparable periods in 2019.
The decrease in income based fees for the three and nine months ended September 30, 2020 from the comparable periods in 2019 was primarily due to the pre-incentive fee net investment income, as defined in the investment advisory and management agreement, for the three and nine months ended September 30, 2020 being lower than in the comparable periods in 2019. Further, in connection with the acquisition of American Capital, Ltd. (“American Capital”) (“the “American Capital Acquisition”), Ares Capital Management waived $10 million of income based fees for each of the ten calendar quarters beginning with the second calendar quarter of 2017 and ending with the third calendar quarter of 2019 (the “Fee Waiver”). The three and nine months ended September 30, 2019 reflect the Fee Waiver of $10 million and $30 million, respectively. Pursuant to the terms under the investment advisory and management agreement, payment of $83 million of the income based fees earned by our investment adviser during the nine months ended September 30, 2020 has been deferred as further discussed below.
For the three months ended September 30, 2020, there was no capital gains incentive fee as calculated in accordance with GAAP. For the nine months ended September 30, 2020, the reduction in the capital gains incentive fee calculated in accordance with GAAP was $58 million. For the three and nine months ended September 30, 2019, the reduction in the capital gains incentive fee expense calculated in accordance with GAAP was $8 million and $7 million, respectively. The capital gains incentive fee accrual for the nine months ended September 30, 2020 changed from the comparable period in 2019 primarily due to net losses on investments, foreign currency and other transactions of $459 million compared to net losses of $32 million for the nine months ended September 30, 2019. The capital gains incentive fee accrued under GAAP includes an accrual related to unrealized capital appreciation, whereas the capital gains incentive fee actually payable under our investment advisory and management agreement does not. There can be no assurance that such unrealized capital appreciation will be realized in the future. The accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reduction of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. As of September 30, 2020, there was no capital gains incentive fee accrued in accordance with GAAP. As of September 30, 2020 and 2019, there was no capital gains incentive fee actually payable under our investment advisory and management agreement. See Note 3 to our consolidated financial statements for the three and nine months ended September 30, 2020, for more information on the base management fees, income based fees and capital gains incentive fees.
Cash payment of any income based fees and capital gains incentive fees otherwise earned by our investment adviser is deferred if during the most recent four full calendar quarter period ending on or prior to the date such payment is to be made the sum of (a) the aggregate distributions to our stockholders and (b) the change in net assets (defined as total assets less indebtedness and before taking into account any income based fees and capital gains incentive fees payable during the period) is less than 7.0% of our net assets (defined as total assets less indebtedness) at the beginning of such period. These calculations will be adjusted for any share issuances or repurchases. Pursuant to these terms, payment of $83 million of the in income based fees earned by our investment adviser for the nine months ended September 30, 2020 has been deferred and carried over for payment in subsequent calculation periods to the extent such fees are payable under the terms of the investment advisory and management agreement. There are currently no capital gains fees payable. See Note 3 to our consolidated financial statements for the three and nine months ended September 30, 2020, for more information on the related deferral terms.
Administrative fees represent fees paid to Ares Operations for our allocable portion of overhead and other expenses incurred by Ares Operations in performing its obligations under the administration agreement, including our allocable portion of the compensation, rent and other expenses of certain of our executive officers and their respective staffs. See Note 3 to our consolidated financial statements for the three and nine months ended September 30, 2020, for more information on the administrative fees.
Other general and administrative expenses include, among other costs, professional fees, insurance, fees and expenses related to evaluating and making investments in portfolio companies and independent directors’ fees.
Income Tax Expense, Including Excise Tax
We have elected to be treated as a RIC under the Code and operate in a manner so as to qualify for the tax treatment applicable to RICs. To qualify as a RIC, we must (among other requirements) meet certain source-of-income and asset diversification requirements and timely distribute to our stockholders at least 90% of our investment company taxable income, as defined by the Code, for each year. We have made and intend to continue to make the requisite distributions to our stockholders which will generally relieve us from U.S. federal corporate-level income taxes.
Depending on the level of taxable income earned in a tax year, we may choose to carry forward such taxable income in excess of current year dividend distributions from such current year taxable income into the next tax year and pay a 4% excise tax on such income, as required. To the extent that we determine that our estimated current year taxable income will be in excess of estimated dividend distributions for the current year from such income, we accrue excise tax, if any, on estimated excess taxable income as such taxable income is earned. For the three and nine months ended September 30, 2020, we recorded a net expense of $4 million and $11 million, respectively, for U.S. federal excise tax. For the three and nine months ended September 30, 2019, we recorded a net expense of $3 million and $10 million, respectively, for U.S. federal excise tax.
Certain of our consolidated subsidiaries are subject to U.S. federal and state income taxes. For the three and nine months ended September 30, 2020, we recorded a net tax expense of $1 million and $1 million, respectively, for these subsidiaries. For the three and nine months ended September 30, 2019, we recorded a net tax expense of $2 million and $3 million, respectively, for these subsidiaries. The income tax expense for our taxable consolidated subsidiaries will vary depending on the level of realized gains from the exits of investments held by such taxable subsidiaries during the respective periods.
Net Realized Gains/Losses
The net realized gains (losses) from the sales, repayments or exits of investments during the three and nine months ended September 30, 2020 and 2019 were comprised of the following:
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Sales, repayments or exits of investments(1) | $448 | $1,190 | $3,124 | $3,828 |
| Net realized gains on investments: | ||||
| Gross realized gains | 9 | 25 | 87 | 57 |
| Gross realized losses | (32) | (99) | (65) | (106) |
| Total net realized gains (losses) on investments | $(23) | $(74) | $22 | $(49) |
(1) Includes $19 million and $798 million of loans sold to IHAM and certain vehicles managed by IHAM during the three and nine months ended September 30, 2020, respectively, and $109 million and $876 million during the comparable periods in 2019, respectively. Net realized losses of $0 million and $21 million were recognized on these transactions with IHAM during the three and nine months ended September 30, 2020, respectively. Net realized losses of $0 million and $2 million were recognized on these transactions with IHAM during the three and nine months ended September 30, 2019, respectively. See Note 4 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information on IHAM and its managed vehicles.
The net realized losses on investments during the three months ended September 30, 2020 consisted of the following:
| (in millions) Portfolio Company | Net Realized Gains (Losses) |
|---|---|
| Nodality, Inc. | $(12) |
| Other, net | (11) |
| Total | $(23) |
During the three months ended September 30, 2020, we also recognized net realized losses on foreign currency and other transactions of $2 million.
The net realized losses on investments during the three months ended September 30, 2019 consisted of the following:
| (in millions) Portfolio Company | Net Realized Gains (Losses) |
|---|---|
| Soil Safe, Inc. and Soil Safe Acquisition Corp. | $13 |
| New Trident Holdcorp, Inc. and Trident Holding Company, LLC | (96) |
| Other, net | 9 |
| Total | $(74) |
During the three months ended September 30, 2019, we also recognized net realized gains on foreign currency and other transactions of $11 million.
The net realized gains on investments during the nine months ended September 30, 2020 consisted of the following:
| (in millions) Portfolio Company | Net Realized Gains (Losses) |
|---|---|
| UL Holding Co., LLC | $21 |
| PERC Holdings 1 LLC | 16 |
| Dynatrace, Inc. | 11 |
| Nodality, Inc. | (12) |
| Other, net | (14) |
| Total | $22 |
140
During the nine months ended September 30, 2020, we also recognized net realized losses on foreign currency and other transactions of $5 million.
The net realized losses on investments during the nine months ended September 30, 2019 consisted of the following:
| (in millions) Portfolio Company | Net Realized Gains (Losses) |
|---|---|
| Soil Safe, Inc. and Soil Safe Acquisition Corp. | $13 |
| New Trident Holdcorp, Inc. and Trident Holding Company, LLC | (96) |
| Other, net | 34 |
| Total | $(49) |
During the nine months ended September 30, 2019, we recognized net realized gains on foreign currency and other transactions of $9 million. During the nine months ended September 30, 2019, we also recognized a realized gain of $46 million in connection with the receipt of a litigation judgment payment related to a former portfolio company of American Capital.
Net Unrealized Gains/Losses
We value our portfolio investments quarterly and the changes in value are recorded as unrealized gains or losses in our consolidated statement of operations. Net unrealized gains and losses on investments for the three and nine months ended September 30, 2020 and 2019 were comprised of the following:
(in millions)
| For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Unrealized appreciation | $375 | $82 | $271 | $116 |
| Unrealized depreciation | (104) | (139) | (783) | (256) |
| Net unrealized (appreciation) depreciation reversed related to net realized gains or losses(1) | 35 | 81 | 36 | 101 |
| Total net unrealized gains (losses) on investments | $306 | $24 | $(476) | $(39) |
(1) The net unrealized (appreciation) depreciation reversed related to net realized gains or losses represents the unrealized appreciation or depreciation recorded on the related asset at the end of the prior period.
During the nine months ended September 30, 2020, our operating results were negatively impacted by the uncertainty surrounding the COVID-19 pandemic, which has caused severe disruptions in the global economy and negatively impacted the fair value and performance of our investment portfolio. For the three months ended March 31, 2020, the net unrealized losses recorded on investments were largely due to widening credit spreads as market participants expected a higher yield on similar investments given the significant market volatility generated in the early stage of the COVID-19 pandemic. To a lesser extent, the net unrealized losses on investments for the first quarter of 2020 for certain of our portfolio companies also reflected other factors such as specific industry concerns, uncertainty about the duration of business shutdowns and near-term liquidity needs.
In determining the fair value of our portfolio as of September 30, 2020, credit spreads continued to tighten relative to spreads as of March 31, 2020 and June 30, 2020, contributing to the reversal of a portion of the unrealized depreciation recorded on certain investments during the three months ended March 31, 2020. Such reversals are reflected as unrealized appreciation for the three and nine months ended September 30, 2020. In addition, for certain of our portfolio companies, we recorded further unrealized depreciation for the three and nine months ended September 30, 2020 due to the continued impact of the COVID-19 pandemic, including from business shutdowns, government restrictions and/or possible additional liquidity needs. For additional information concerning the COVID-19 pandemic and its potential impact on our business and our operating results, see Part II - Other information, Item 1A. Risk Factors, “Risk Factors - The COVID-19 pandemic has caused severe disruptions in the global economy, which has had, and may continue to have, a negative impact on our portfolio companies and our business and operations.”
The changes in net unrealized appreciation and depreciation on investments during the three months ended September 30, 2020 consisted of the following:
| (in millions) Portfolio Company | Net Unrealized Appreciation (Depreciation) |
|---|---|
| Singer Sewing Company | $70 |
| Senior Direct Lending Program, LLC | 46 |
| Ivy Hill Asset Management, L.P. | 23 |
| Evolent Health LLC and Evolent Health, Inc. | 12 |
| Production Resource Group, L.L.C. | (16) |
| OTG Management, LLC | (22) |
| Other, net | 158 |
| Total | $271 |
During the three months ended September 30, 2020, we also recognized net unrealized losses on foreign currency and other transactions of $6 million.
The changes in net unrealized appreciation and depreciation on investments during the three months ended September 30, 2019 consisted of the following:
| (in millions) Portfolio Company | Net Unrealized Appreciation (Depreciation) |
|---|---|
| Dynatrace, Inc. | $13 |
| Ivy Hill Asset Management, L.P. | (19) |
| Other, net | (51) |
| Total | $(57) |
During the three months ended September 30, 2019, we also recognized net unrealized gains on foreign currency and other transactions of $2 million.
The changes in net unrealized appreciation and depreciation on investments during the nine months ended September 30, 2020 consisted of the following:
| (in millions) Portfolio Company | Net Unrealized Appreciation (Depreciation) |
|---|---|
| Singer Sewing Company | $107 |
| Teasdale Foods, Inc. and Familia Group Holdings Inc. | 12 |
| Absolute Dental Group LLC and Absolute Dental Equity, LLC | 11 |
| Evolent Health LLC and Evolent Health, Inc. | 10 |
| Murchison Oil and Gas, LLC and Murchison Holdings, LLC | (10) |
| Olympia Acquisition, Inc. and Olympia TopCo, L.P. | (10) |
| PERC Holdings 1 LLC | (10) |
| MW Dental Holding Corp. | (11) |
| Cipriani USA, Inc. | (12) |
| FWR Holding Corporation | (12) |
| Alcami Corporation and ACM Holdings I, LLC | (12) |
| Cheyenne Petroleum Company Limited Partnership | (13) |
| Sundance Energy, Inc. | (14) |
| Implus Footcare, LLC | (14) |
| Birch Permian, LLC | (19) |
| Varsity Brands Holding Co., Inc. | (20) |
| Centric Brands Inc. | (21) |
| Penn Virginia Holding Corp. | (23) |
| Garden Fresh Restaurant Corp. | (24) |
| Microstar Logistics LLC | (25) |
| VPROP Operating, LLC and Vista Proppants and Logistics, LLC | (50) |
| Production Resource Group, L.L.C. | (56) |
| OTG Management, LLC | (107) |
| Other, net | (189) |
| Total | $(512) |
The changes in net unrealized appreciation and depreciation on investments during the nine months ended September 30, 2019 consisted of the following:
| (in millions) Portfolio Company | Net Unrealized Appreciation (Depreciation) |
|---|---|
| Dynatrace, Inc. | $13 |
| Instituto de Banca y Comercio, Inc. & Leeds IV Advisors, Inc. | 12 |
| Alcami Corporation | (13) |
| Ivy Hill Asset Management, L.P. | (13) |
| ADG, LLC and RC IV GEDC Investor LLC | (13) |
| Indra Holdings Corp. | (19) |
| Other, net | (107) |
| Total | $(140) |
During the nine months ended September 30, 2019, we also recognized net unrealized losses on foreign currency and other transactions of $7 million.
FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES
Our liquidity and capital resources are generated primarily from the net proceeds of public offerings of equity and debt securities, advances from the Revolving Credit Facility, the Revolving Funding Facility, the SMBC Funding Facility and the BNP Funding Facility (each as defined below, and together, the “Facilities”), net proceeds from the issuance of other securities, including unsecured notes, as well as cash flows from operations.
In accordance with the Investment Company Act, we are allowed to borrow amounts such that our asset coverage, calculated pursuant to the Investment Company Act, is at least 150% after such borrowings (i.e., we are able to borrow up to two dollars for every dollar we have in assets less all liabilities and indebtedness not represented by senior securities issued by us). As of September 30, 2020, we had $233 million in cash and cash equivalents and $7.6 billion in total aggregate principal amount of debt outstanding ($7.6 billion at carrying value) and our asset coverage was 190%. Subject to borrowing base and other restrictions, we had approximately $4.2 billion available for additional borrowings under the Facilities as of September 30, 2020.
We may from time to time seek to retire or repurchase our common stock through cash purchases, as well as retire, cancel or purchase our outstanding debt through cash purchases and/or exchanges, in open market purchases, privately negotiated transactions or otherwise. The amounts involved may be material. In addition, we may from time to time enter into additional debt facilities, increase the size of existing facilities or issue additional debt securities, including secured debt, unsecured debt and/or debt securities convertible into common stock. Any such purchases or exchanges of common stock or outstanding debt, or incurrence or issuance of additional debt would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors.
Equity Capital Activities
As of September 30, 2020 and December 31, 2019, our total equity market capitalization was $5.9 billion and $8.0 billion, respectively.
We are party to equity distribution agreements with two sales agents ( the “Equity Distribution Agreements”), pursuant to which we may from time to time issue and sell shares of our common stock having an aggregate offering amount of up to $500 million. Subject to the terms and conditions of the Equity Distribution Agreements, sales of common stock, if any, may be made in transactions that are deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended. As of September 30, 2020, we had cumulatively issued and sold 3.5 million shares of common stock under the Equity Distribution Agreements, with net proceeds totaling $64 million, after deducting sales agents’ commissions and certain offering expenses of approximately $1 million. As of September 30, 2020, common stock with an aggregate offering amount of $435 million remained available for issuance under the Equity Distribution Agreements. During the nine months ended September 30, 2020, we did not issue any shares of common stock under the Equity Distribution Agreements.
There were no issuances of our equity securities during the nine months ended September 30, 2020 and 2019.
We are authorized under our stock repurchase program to purchase up to $500 million in the aggregate of our outstanding common stock in the open market at certain thresholds below our net asset value per share, in accordance with the guidelines specified in Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The timing, manner, price and amount of any share repurchases will be determined by us, in our discretion, based upon the evaluation of economic and market conditions, stock price, applicable legal and regulatory requirements and other factors. The program does not require us to repurchase any specific number of shares, and we cannot assure stockholders that any shares will be repurchased under the program. The expiration date of the stock repurchase program is February 15, 2021. The program may be suspended, extended, modified or discontinued at any time.
As of September 30, 2020, we had repurchased a total of 9.0 million shares of our common stock in the open market under the stock repurchase program since its inception in September 2015, at an average price of $11.95 per share, including commissions paid, leaving approximately $393 million available for additional repurchases under the program. During the nine months ended September 30, 2020, we repurchased a total of 8.5 million shares of our common stock in the open market under the stock repurchase program for $100 million. The shares were repurchased at an average price of $11.83 per share, including commissions paid. During the nine months ended September 30, 2019, we did not repurchase any shares of our common stock under the stock repurchase program.
Debt Capital Activities
Our debt obligations consisted of the following as of September 30, 2020 and December 31, 2019:
(in millions)
| As of September 30, 2020 Total Aggregate Principal Amount Available/ Outstanding(1) | Principal Amount Outstanding | Carrying Value | December 31, 2019 Total Aggregate Principal Amount Available/ Outstanding(1) | Principal Amount Outstanding | Carrying Value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Revolving Credit Facility | $3,617 | (2) | $849 | $849 | $3,365 | $2,250 | $2,250 | ||
| Revolving Funding Facility | 1,525 | 663 | 663 | 1,275 | 638 | 638 | |||
| SMBC Funding Facility | 725 | (3) | 363 | 363 | 650 | 301 | 301 | ||
| BNP Funding Facility | 300 | — | — | — | — | — | |||
| 2022 Convertible Notes | 388 | 388 | 381 | (4) | 388 | 388 | 377 | (4) | |
| 2024 Convertible Notes | 403 | 403 | 391 | (4) | 403 | 403 | 389 | (4) | |
| 2022 Notes | 600 | 600 | 598 | (5) | 600 | 600 | 597 | (5) | |
| 2023 Notes | 750 | 750 | 747 | (6) | 750 | 750 | 746 | (6) | |
| 2024 Notes | 900 | 900 | 896 | (7) | 900 | 900 | 895 | (7) | |
| March 2025 Notes | 600 | 600 | 595 | (8) | 600 | 600 | 594 | (8) | |
| July 2025 Notes | 750 | 750 | 741 | (9) | — | — | — | ||
| 2026 Notes | 1,150 | 1,150 | 1,141 | (10) | — | — | — | (10) | |
| 2047 Notes | 230 | 230 | 185 | (11) | 230 | 230 | 184 | (11) | |
| Total | $11,938 | $7,646 | $7,550 | $9,161 | $7,060 | $6,971 |
(1) Represents the total aggregate amount committed or outstanding, as applicable, under such instrument. Borrowings under the committed Revolving Credit Facility, Revolving Funding Facility, SMBC Funding Facility and BNP Funding Facility (each as defined below) are subject to borrowing base and other restrictions.
(2) Provides for a feature that allows us, under certain circumstances, to increase the size of the Revolving Credit Facility (as defined below) to a maximum of $5.4 billion.
(3) Provides for a feature that allows ACJB (as defined below), under certain circumstances, to increase the size of the SMBC Funding Facility (as defined below) to a maximum of $1.0 billion.
(4) Represents the aggregate principal amount outstanding of the Convertible Unsecured Notes (as defined below). As of September 30, 2020, the total unamortized debt issuance costs and the unaccreted discount for the 2022 Convertible Notes and the 2024 Convertible Notes (each as defined below) were $7 million and $12 million, respectively. As of December 31, 2019, the total unamortized debt issuance costs and the unaccreted discount for the 2022 Convertible Notes and the 2024 Convertible Notes were $11 million and $14 million, respectively.
(5) Represents the aggregate principal amount outstanding of the 2022 Notes (as defined below), less unamortized debt issuance costs and the unaccreted discount recorded upon the issuance of the 2022 Notes. As of September 30, 2020 and December 31, 2019, the total unamortized debt issuance costs and unaccreted discount was $2 million and $3 million, respectively.
(6) Represents the aggregate principal amount outstanding of the 2023 Notes (as defined below), less unamortized debt issuance costs and the unaccreted discount recorded upon the issuance of the 2023 Notes. As of September 30, 2020 and December 31, 2019, the total unamortized debt issuance costs and unaccreted discount was $3 million and $4 million, respectively.
(7) Represents the aggregate principal amount outstanding of the 2024 Notes (as defined below), less unamortized debt issuance costs and the net unaccreted discount recorded upon the issuance of the 2024 Notes. As of September 30, 2020 and December 31, 2019, the total unamortized debt issuance costs and net unaccreted discount was $4 million and $5 million, respectively.
(8) Represents the aggregate principal amount outstanding of the March 2025 Notes (as defined below), less unamortized debt issuance costs and the unaccreted discount recorded upon the issuance of the March 2025 Notes. As of September 30, 2020 and December 31, 2019, the total unamortized debt issuance costs and unaccreted discount was $5 million and $6 million, respectively.
(9) Represents the aggregate principal amount outstanding of the July 2025 Notes (as defined below), less unamortized debt issuance costs and the unaccreted discount recorded upon the issuance of the July 2025 Notes. As of September 30, 2020, the total unamortized debt issuance costs and unaccreted discount was $9 million.
(10) Represents the aggregate principal amount outstanding of the 2026 Notes (as defined below), less unamortized debt issuance costs and the unaccreted discount recorded upon the issuance of the 2026 Notes. As of September 30, 2020, the total unamortized debt issuance costs and net unaccreted discount was $9 million.
(11) Represents the aggregate principal amount outstanding of the 2047 Notes (as defined below), less unamortized debt issuance costs and unaccreted discount recorded as part of the Allied Acquisition (as defined below). As of September 30, 2020 and December 31, 2019, the total unaccreted purchased discount was $45 million and $46 million, respectively.
The weighted average stated interest rate and weighted average maturity, both on aggregate principal amount outstanding, of all our debt outstanding as of September 30, 2020 were 3.5% and 4.5 years, respectively, and as of December 31, 2019 were 3.9% and 4.7 years, respectively.
The ratio of total principal amount of debt outstanding to stockholders’ equity as of September 30, 2020 was 1.10:1.00 compared to 0.95:1.00 as of December 31, 2019.
Revolving Credit Facility
We are party to a senior secured revolving credit facility (as amended and restated, the “Revolving Credit Facility”), that allows us to borrow up to $3.6 billion at any one time outstanding. The Revolving Credit Facility consists of a $740 million term loan tranche and a $2.9 billion revolving tranche. For $699 million of the term loan tranche, the stated maturity date is March 30, 2025. For the remaining $41 million of the term loan tranche, the stated maturity date is March 30, 2024. For $2.7 billion of the revolving tranche, the end of the revolving period and the stated maturity date are March 30, 2024 and March 30, 2025, respectively. For the remaining $124 million of the revolving tranche, the end of the revolving period and the stated maturity date are March 30, 2023 and March 30, 2024, respectively. The Revolving Credit Facility also provides for a feature that allows us, under certain circumstances, to increase the overall size of the Revolving Credit Facility to a maximum of $5.4 billion. The interest rate charged on the Revolving Credit Facility is based on an applicable spread of either 1.75% or 1.875% over LIBOR or 0.75% or 0.875% over an “alternate base rate” (as defined in the agreements governing the Revolving Credit Facility), in each case, determined monthly based on the total amount of the borrowing base relative to the total commitments of the Revolving Credit Facility and other debt, if any, secured by the same collateral as the Revolving Credit Facility. As of September 30, 2020, the interest rate in effect was LIBOR plus 1.875%. We are also required to pay a letter of credit fee of either 2.00% or 2.125% per annum on letters of credit issued, determined monthly based on the total amount of the borrowing base relative to the total commitments of the Revolving Credit Facility and other debt, if any, secured by the same collateral as the Revolving Credit Facility. Additionally, we are required to pay a commitment fee of 0.375% per annum on any unused portion of the Revolving Credit Facility. As of September 30, 2020, there was $849 million outstanding under the Revolving Credit Facility and we were in compliance in all material respects with the terms of the Revolving Credit Facility.
Revolving Funding Facility
We and our consolidated subsidiary, Ares Capital CP Funding LLC (“Ares Capital CP”), are party to a revolving funding facility (as amended, the “Revolving Funding Facility”), that allows Ares Capital CP to borrow up to $1.5 billion at any one time outstanding. The Revolving Funding Facility is secured by all of the assets held by, and the membership interest in, Ares Capital CP. The end of the reinvestment period and the stated maturity date for the Revolving Funding Facility are January 31, 2023 and January 31, 2025, respectively. The interest rate charged on the Revolving Funding Facility is based on LIBOR plus 2.00% per annum or a “base rate” (as defined in the agreements governing the Revolving Funding Facility) plus
1.00% per annum. Ares Capital CP is also required to pay a commitment fee of between 0.50% and 1.50% per annum depending on the size of the unused portion of the Revolving Funding Facility. As of September 30, 2020, there was $663 million outstanding under the Revolving Funding Facility and we and Ares Capital CP were in compliance in all material respects with the terms of the Revolving Funding Facility.
SMBC Funding Facility
We and our consolidated subsidiary, Ares Capital JB Funding LLC (“ACJB”), are party to a revolving funding facility (as amended, the “SMBC Funding Facility”) with ACJB, as the borrower, and Sumitomo Mitsui Banking Corporation, as the administrative agent and collateral agent, that allows ACJB to borrow up to $725 million at any one time outstanding. The SMBC Funding Facility also provides for a feature that allows ACJB, subject to receiving certain consents, to increase the overall size of the SMBC Funding Facility to $1.0 billion. The SMBC Funding Facility is secured by all of the assets held by ACJB. The end of the reinvestment period and the stated maturity date for the SMBC Funding Facility are September 10, 2022 and September 10, 2024, respectively. The reinvestment period and the stated maturity date are both subject to two one-year extensions by mutual agreement. The interest rate charged on the SMBC Funding Facility is based on an applicable spread of either 1.75% or 2.00% over LIBOR or 0.75% or 1.00% over a “base rate” (as defined in the agreements governing the SMBC Funding Facility), in each case, determined monthly based on the amount of the average borrowings outstanding under the SMBC Funding Facility. As of September 30, 2020, the interest rate in effect was LIBOR plus 1.75%. ACJB is also required to pay a commitment fee of between 0.50% and 1.00% per annum depending on the size of the unused portion of the SMBC Funding Facility. As of September 30, 2020, there was $363 million outstanding under the SMBC Funding Facility and we and ACJB were in compliance in all material respects with the terms of the SMBC Funding Facility.
BNP Funding Facility
We and our consolidated subsidiary, ARCC FB Funding LLC (“AFB”), are party to a revolving funding facility (the “BNP Funding Facility”) with AFB, as the borrower, and BNP Paribas, as the administrative agent and lender, that allows AFB to borrow up to $300 million at any one time outstanding. The BNP Funding Facility is secured by all of the assets held by AFB. The end of the reinvestment period and the stated maturity date for the BNP Funding Facility are June 11, 2023 and June 11, 2025, respectively. The reinvestment period and the stated maturity date are both subject to a one-year extension by mutual agreement. The interest rate charged on the BNP Funding Facility is based on three month LIBOR (subject to a floor of 0.45%), or over a “base rate” (as defined in the agreements governing the BNP Funding Facility) plus a margin that generally ranges between 2.65% and 3.15% (depending on the types of assets such advances relate to), with a weighted average floor for all classes of advances of (i) 2.75% during the reinvestment period and (ii) 3.25% following the reinvestment period. Prior to December 11, 2020, there is no commitment fee required to be paid. Beginning on December 11, 2020, AFB will be required to pay a commitment fee of between 0.00% and 1.25% per annum depending on the size of the unused portion of the BNP Funding Facility. As of September 30, 2020, there were no amounts outstanding under the BNP Funding Facility and we and AFB were in compliance in all material respects with the terms of the BNP Funding Facility.
Convertible Unsecured Notes
We have issued $388 million in aggregate principal amount of unsecured convertible notes that mature on February 1, 2022 (the “2022 Convertible Notes”) and $403 million in aggregate principal amount of unsecured convertible notes that mature on March 1, 2024 (the “2024 Convertible Notes” and together with the 2022 Convertible Notes, the “Convertible Unsecured Notes”). The Convertible Unsecured Notes mature upon their respective maturity dates unless previously converted or repurchased in accordance with their terms. We do not have the right to redeem the Convertible Unsecured Notes prior to maturity. The 2022 Convertible Notes and the 2024 Convertible Notes bear interest at a rate of 3.75% and 4.625%, respectively, per annum, payable semi-annually.
In certain circumstances, assuming the respective conversion date below has not already passed, the Convertible Unsecured Notes will be convertible into cash, shares of our common stock or a combination of cash and shares of our common stock, at our election, at their respective conversion rates (listed below as of September 30, 2020) subject to customary anti-dilution adjustments and the requirements of their respective indenture (the “Convertible Unsecured Notes Indentures”). Prior to the close of business on the business day immediately preceding their respective conversion date (listed below), holders may convert their Convertible Unsecured Notes only under certain circumstances set forth in the Convertible Unsecured Notes Indentures. On or after their respective conversion dates until the close of business on the scheduled trading day immediately preceding the maturity date for the 2022 Convertible Notes and the second scheduled trading day immediately preceding the maturity date for the 2024 Convertible Notes, holders may convert their Convertible Unsecured Notes at any time. In addition, if we engage in certain corporate events as described in their respective Convertible Unsecured Notes Indenture, holders of the Convertible Unsecured Notes may require us to repurchase for cash all or part of the Convertible
Unsecured Notes at a repurchase price equal to 100% of the principal amount of the Convertible Unsecured Notes to be repurchased, plus accrued and unpaid interest through, but excluding, the required repurchase date.
Certain key terms related to the convertible features for each of the Convertible Unsecured Notes as of September 30, 2020 are listed below.
| 2022 Convertible Notes | 2024 Convertible Notes | |
|---|---|---|
| Conversion premium | 15.0% | 15.0% |
| Closing stock price at issuance | $16.86 | $17.29 |
| Closing stock price date | January 23, 2017 | March 5, 2019 |
| Conversion price(1) | $19.11 | $19.88 |
| Conversion rate (shares per one thousand dollar principal amount)(1) | 52.3163 | 50.2930 |
| Conversion dates | August 1, 2021 | December 1, 2023 |
(1) Represents conversion price and conversion rate, as applicable, as of September 30, 2020, taking into account any applicable de minimis adjustments that will be made on the conversion date.
Unsecured Notes
2022 Notes
We have issued $600 million in aggregate principal amount of unsecured notes, that mature on January 19, 2022 and
bear interest at a rate of 3.625% per annum (the “2022 Notes”). The 2022 Notes pay interest semi-annually, and all principal is due upon maturity. The 2022 Notes may be redeemed in whole or in part at any time at our option at a redemption price equal to par plus a “make whole” premium, if applicable, as determined pursuant to the indenture governing the 2022 Notes, and any accrued and unpaid interest.
2023 Notes
We have issued $750 million in aggregate principal amount of unsecured notes that mature on February 10, 2023 and bear interest at a rate of 3.500% per annum (the “2023 Notes”). The 2023 Notes pay interest semi-annually, and all principal is due upon maturity. The 2023 Notes may be redeemed in whole or in part at any time at our option at a redemption price equal to par plus a “make whole” premium, if applicable, as determined pursuant to the indenture governing the 2023 Notes, and any accrued and unpaid interest.
2024 Notes
We have issued $900 million in aggregate principal amount of unsecured notes that mature on June 10, 2024 and bear interest at a rate of 4.200% per annum (the ‘‘2024 Notes’’). The 2024 Notes pay interest semi-annually, and all principal is due upon maturity. The 2024 Notes may be redeemed in whole or in part at any time at our option at a redemption price equal to par plus a ‘‘make whole’’ premium, if applicable, as determined pursuant to the indenture governing the 2024 Notes, and any accrued and unpaid interest.
March 2025 Notes
We have issued $600 million in aggregate principal amount of unsecured notes that mature on March 1, 2025 and bear interest at a rate of 4.250% per annum (the “March 2025 Notes”). The March 2025 Notes pay interest semi-annually, and all principal is due upon maturity. The March 2025 Notes may be redeemed in whole or in part at any time at our option at a redemption price equal to par plus a “make whole” premium, if applicable, as determined pursuant to the indenture governing the March 2025 Notes, and any accrued and unpaid interest.
July 2025 Notes
We issued $750 million in aggregate principal amount of unsecured notes that mature on July 15, 2025 and bear interest at a rate of 3.250% per annum (the ‘‘July 2025 Notes’’). The July 2025 Notes pay interest semi-annually, and all principal is due upon maturity. The July 2025 Notes may be redeemed in whole or in part at any time at our option at a redemption price equal to par plus a ‘‘make whole’’ premium, if applicable, as determined pursuant to the indenture governing the July 2025 Notes, and any accrued and unpaid interest.
2026 Notes
We issued $1,150 million in aggregate principal amount of unsecured notes that mature on January 15, 2026 and bear interest at a rate of 3.875% per annum (the ‘‘2026 Notes’’). The 2026 Notes pay interest semi-annually, and all principal is due upon maturity. The 2026 Notes may be redeemed in whole or in part at any time at our option at a redemption price equal to par plus a ‘‘make whole’’ premium, if applicable, as determined pursuant to the indenture governing the 2026 Notes, and any accrued and unpaid interest.
2047 Notes
As part of the Allied Acquisition, we assumed $230 million in aggregate principal amount of unsecured notes that mature on April 15, 2047 and bear interest at a rate of 6.875% per annum (the “2047 Notes” and together with the 2022 Notes, the 2023 Notes, the 2024 Notes, the March 2025 Notes, the July 2025 Notes and the 2026 Notes, the “Unsecured Notes”). The 2047 Notes pay interest quarterly, and all principal is due upon maturity. The 2047 Notes may be redeemed in whole or in part at any time or from time to time at our option, at a par redemption price of $25.00 per security plus accrued and unpaid interest.
As of September 30, 2020, we were in compliance in all material respects with the terms of the Convertible Unsecured Notes Indentures and the indentures governing the Unsecured Notes.
The Convertible Unsecured Notes and the Unsecured Notes are our senior unsecured obligations and rank senior in right of payment to any future indebtedness that is expressly subordinated in right of payment to the Convertible Unsecured Notes and the Unsecured Notes; equal in right of payment to our existing and future unsecured indebtedness that is not expressly subordinated; effectively junior in right of payment to any of our secured indebtedness (including existing unsecured indebtedness that we later secure) to the extent of the value of the assets securing such indebtedness; and structurally junior to all existing and future indebtedness (including trade payables) incurred by our subsidiaries, financing vehicles or similar facilities.
See Note 5 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information on our debt obligations.
OFF BALANCE SHEET ARRANGEMENTS
We have various commitments to fund investments in our portfolio, as described below.
As of September 30, 2020 and December 31, 2019, we had the following commitments to fund various revolving and delayed draw senior secured and subordinated loans, including commitments to fund which are at (or substantially at) our discretion:
(in millions)
| As of September 30, 2020 | December 31, 2019 | |
|---|---|---|
| Total revolving and delayed draw loan commitments | $2,002 | $2,009 |
| Less: funded commitments | (534) | (460) |
| Total unfunded commitments | 1,468 | 1,549 |
| Less: commitments substantially at our discretion | (18) | (6) |
| Less: unavailable commitments due to borrowing base or other covenant restrictions | (116) | — |
| Total net adjusted unfunded revolving and delayed draw loan commitments | $1,334 | $1,543 |
Included within the total revolving and delayed draw loan commitments as of September 30, 2020 and December 31, 2019 were delayed draw loan commitments totaling $595 million and $633 million, respectively. Our commitment to fund delayed draw loans is triggered upon the satisfaction of certain pre-negotiated terms and conditions. Generally, the most significant and uncertain term requires the borrower to satisfy a specific use of proceeds covenant. The use of proceeds covenant typically requires the borrower to use the additional loans for the specific purpose of a permitted acquisition or permitted investment, for example. In addition to the use of proceeds covenant, the borrower is generally required to satisfy additional negotiated covenants (including specified leverage levels).
Also included within the total revolving loan commitments as of September 30, 2020 were commitments to issue up to $355 million in letters of credit through a financial intermediary on behalf of certain portfolio companies. As of September 30, 2020, we had $46 million in letters of credit issued and outstanding under these commitments on behalf of the portfolio companies. For all these letters of credit issued and outstanding, we would be required to make payments to third parties if the portfolio companies were to default on their related payment obligations. Of these letters of credit, $1 million expire in 2020, $44 million expire in 2021 and $1 expire in 2024. As of September 30, 2020, we recorded a liability of $1 million for certain letters of credit issued and outstanding and none of the other letters of credit issued and outstanding were recorded as a liability on our balance sheet as such other letters of credit are considered in the valuation of the investments in the portfolio company.
We also have commitments to co-invest in the SDLP for our portion of the SDLP’s commitments to fund delayed draw loans to certain portfolio companies of the SDLP. See “Senior Direct Lending Program” above and Note 4 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information.
As of September 30, 2020 and December 31, 2019, we were party to subscription agreements to fund equity investments in private equity investment partnerships as follows:
(in millions)
| As of September 30, 2020 | December 31, 2019 | |
|---|---|---|
| Total private equity commitments | $108 | $110 |
| Less: funded private equity commitments | (65) | (62) |
| Total unfunded private equity commitments | 43 | 48 |
| Less: private equity commitments substantially our discretion | (43) | (48) |
| Total net adjusted unfunded private equity commitments | $— | $— |
In the ordinary course of business, we may sell certain of our investments to third party purchasers. In particular, in connection with the sale of certain controlled portfolio company equity investments (as well as certain other sales), we have, and may continue to do so in the future, agreed to indemnify such purchasers for future liabilities arising from the investments and the related sale transaction. Such indemnification provisions have given rise to liabilities in the past and may do so in the future.
In addition, in the ordinary course of business, we may guarantee certain obligations in connection with our portfolio companies (in particular, certain controlled portfolio companies). Under these guarantee arrangements, payments may be required to be made to third parties if such guarantees are called upon or if the portfolio companies were to default on their related obligations, as applicable.
RECENT DEVELOPMENTS
From October 1, 2020 through October 21, 2020, we made new investment commitments of approximately $419 million, of which $341 million were funded. Of these new commitments, 51% were in first lien senior secured loans, 47% were in second lien senior secured loans, 1% were in preferred equity securities and 1% were in other equity securities. Of the approximately $419 million of new investment commitments, 98% were floating rate, 1% were fixed rate and 1% were non-income producing. The weighted average yield of debt and other income producing securities funded during the period at amortized cost was 8.7%. We may seek to sell all or a portion of these new investment commitments, although there can be no assurance that we will be able to do so.
From October 1, 2020 through October 21, 2020, we exited approximately $326 million of investment commitments. Of the total investment commitments exited, 61% were first lien senior secured loans, 22% were second lien senior secured loans, 9% were senior subordinated loans and 8% were other equity securities. Of the approximately $326 million of exited investment commitments, 54% were floating rate, 38% were on non-accrual and 8% were non-income producing. The weighted average yield of debt and other income producing securities exited or repaid during the period at amortized cost was 7.7%, and the weighted average yield on total investments exited or repaid during the period at amortized cost was 4.3%. On the approximately $326 million of investment commitments exited from October 1, 2020 through October 21, 2020, we recognized total net realized losses of approximately $83 million.
In addition, as of October 21, 2020, we had an investment backlog and pipeline of approximately $1.5 billion and $75 million, respectively. Investment backlog includes transactions approved by our investment adviser’s investment committee and/or for which a formal mandate, letter of intent or a signed commitment have been issued, and therefore we believe are likely to close. Investment pipeline includes transactions where due diligence and analysis are in process, but no formal mandate, letter of intent or signed commitment have been issued. The consummation of any of the investments in this backlog and pipeline depends upon, among other things, one or more of the following: satisfactory completion of our due diligence investigation of the prospective portfolio company, our acceptance of the terms and structure of such investment and the execution and delivery of satisfactory transaction documentation. In addition, we may sell all or a portion of these investments and certain of these investments may result in the repayment of existing investments. We cannot assure you that we will make any of these investments or that we will sell all or any portion of these investments.
CRITICAL ACCOUNTING POLICIES
The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. Our critical accounting policies, including those relating to the valuation of our investment portfolio, are described below. The critical accounting policies should be read in conjunction with our risk factors in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in this Quarterly Report. See Note 2 to our consolidated financial statements for the three and nine months ended September 30, 2020, for more information on our significant accounting policies.
Investments
Investment transactions are recorded on the trade date. Realized gains or losses are measured by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include investments charged off during the period, net of recoveries. Unrealized gains or losses primarily reflect the change in investment values, including the reversal of previously recorded unrealized gains or losses when gains or losses are realized.
Investments for which market quotations are readily available are typically valued at such market quotations. In order to validate market quotations, we look at a number of factors to determine if the quotations are representative of fair value, including the source and nature of the quotations. Debt and equity securities that are not publicly traded or whose market prices are not readily available (i.e., substantially all of our investments) are valued at fair value as determined in good faith by our board of directors, based on, among other things, the input of our investment adviser, audit committee and independent third‑party valuation firms that have been engaged at the direction of our board of directors to assist in the valuation of each portfolio investment without a readily available market quotation at least once during a trailing 12‑month period (with certain de minimis exceptions) and under a valuation policy and a consistently applied valuation process. The valuation process is conducted at the end of each fiscal quarter, and a portion of our investment portfolio at fair value is subject to review by an independent third-party valuation firm each quarter. In addition, our independent registered public accounting firm obtains an understanding of, and performs select procedures relating to, our investment valuation process within the context of performing the integrated audit.
As part of the valuation process, we may take into account the following types of factors, if relevant, in determining the fair value of our investments: the enterprise value of a portfolio company (the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time), the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings and discounted cash flow, the markets in which the portfolio company does business, a comparison of the portfolio company’s securities to any similar publicly traded securities, changes in the interest rate environment and the credit markets, which may affect the price at which similar investments would trade in their principal markets and other relevant factors. When an external event such as a purchase transaction, public offering or subsequent sale occurs, we consider the pricing indicated by the external event to corroborate our valuation.
Because there is not a readily available market value for most of the investments in our portfolio, we value substantially all of our portfolio investments at fair value as determined in good faith by our board of directors, as described herein. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period. Additionally, the fair value of our investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that we may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we could realize significantly less than the value at which we have recorded it.
In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned.
Our board of directors undertakes a multi‑step valuation process each quarter, as described below:
- Our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals responsible for the portfolio investment in conjunction with our portfolio management team.
- Preliminary valuations are reviewed and discussed with our investment adviser’s management and investment professionals, and then valuation recommendations are presented to our board of directors.
- The audit committee of our board of directors reviews these valuations, as well as the input of third parties, including independent third‑party valuation firms who have reviewed a portion of the investments in our portfolio at fair value.
- Our board of directors discusses valuations and ultimately determines the fair value of each investment in our portfolio without a readily available market quotation in good faith based on, among other things, the input of our investment adviser, audit committee and, where applicable, independent third‑party valuation firms.
Fair Value of Financial Instruments
We follow ASC 825-10, R*ecognition and Measurement of Financial Assets and Financial Liabilities (“*ASC 825-10”), which provides companies the option to report selected financial assets and liabilities at fair value. ASC 825-10 also establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities and to more easily understand the effect of the company’s choice to use fair value on its earnings. ASC 825-10 also requires entities to display the fair value of the selected assets and liabilities on the face of the balance sheet. We have not elected the ASC 825-10 option to report selected financial assets and liabilities at fair value. With the exception of the line items entitled “other assets” and “debt,” which are reported at amortized cost, all assets and liabilities approximate fair value on the balance sheet. The carrying value of the lines titled “interest receivable,” “receivable for open trades,” “operating lease right-of-use asset,” “payable for open trades,” “accounts payable and other liabilities,” “base management fees payable,” “income based fees payable,” “capital gains incentive fees payable,” “interest and facility fees payable,” “operating lease liabilities” and “payable to participants” approximate fair value due to their short maturity.
We also follow ASC 820-10, which expands the application of fair value accounting. ASC 820-10 defines fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosure of fair value measurements. ASC 820-10 determines fair value to be the price that would be received for an investment in a current sale, which assumes an orderly transaction between market participants on the measurement date. ASC 820-10 requires us to assume that the portfolio investment is sold in its principal market to market participants or, in the absence of a principal market, the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact. In accordance with ASC 820-10, we have considered its principal market as the market in which we exit our portfolio investments with the greatest volume and level of activity. ASC 820-10 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. In accordance with ASC 820-10, these inputs are summarized in the three broad levels listed below:
- Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that we have the ability to access.
- Level 2 - Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
- Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
In addition to using the above inputs in investment valuations, we continue to employ the net asset valuation policy approved by our board of directors that is consistent with ASC 820-10. Consistent with our valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. Our valuation policy considers the fact that because there is not a readily available market value for most of the investments in our portfolio, the fair value of the investments must typically be determined using unobservable inputs.
Our portfolio investments (other than as described below in the following paragraph) are typically valued using two different valuation techniques. The first valuation technique is an analysis of the enterprise value (“EV”) of the portfolio company. Enterprise value means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The primary method for determining EV uses a multiple analysis whereby appropriate multiples are applied to the portfolio company’s EBITDA (generally defined as net income before net interest expense, income tax expense, depreciation and amortization). EBITDA multiples are typically determined based upon review of market comparable transactions and publicly traded comparable companies, if any. We may also employ other valuation multiples to determine EV, such as revenues or, in the case of certain portfolio companies in the power generation industry, kilowatt capacity. The second method for determining EV uses a discounted cash flow analysis whereby future expected cash flows of the portfolio company are discounted to determine a present value using estimated discount rates (typically a weighted average cost of capital based on costs of debt and equity consistent with current market conditions). The EV analysis is performed to determine the value of equity investments, the value of debt investments in portfolio companies where we have control or could gain control through an option or warrant security, and to determine if there is credit impairment for debt investments. If debt investments are credit impaired, an EV analysis may be used to value such debt investments; however, in addition to the methods outlined above, other methods such as a liquidation or wind-down analysis may be utilized to estimate enterprise value. The second valuation technique is a yield analysis, which is typically performed for non-credit impaired debt investments in portfolio companies where the we do not own a controlling equity position. To determine fair value using a yield analysis, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk. In the yield analysis, we consider the current contractual interest rate, the maturity and other terms of the investment relative to the risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the enterprise value of the portfolio company. As debt investments held by us are substantially illiquid with no active transaction market, we depend on primary market data, including newly funded transactions, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.
For other portfolio investments such as investments in the SDLP Certificates, discounted cash flow analysis is the primary technique utilized to determine fair value. Expected future cash flows associated with the investment are discounted to determine a present value using a discount rate that reflects estimated market return requirements.
See Note 8 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information on our valuation process.
Market risk
As filed, 7,605 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are subject to financial market risks, including changes in interest rates and the valuations of our investment portfolio. Uncertainty with respect to the economic effects of the COVID-19 outbreak has introduced significant volatility in the financial markets, and the effects of this volatility could materially impact our market risks, including those listed below. For additional information concerning the COVID-19 pandemic and its potential impact on our business and our operating results, see Part II - Other information, Item 1A. Risk Factors, “Risk Factors - The COVID-19 pandemic has caused severe disruptions in the global economy, which has had, and may continue to have, a negative impact on our portfolio companies and our business and operations.”
Investment valuation risk
Because there is not a readily available market value for most of the investments in our portfolio, we value substantially all of our portfolio investments at fair value as determined in good faith by our board of directors based on, among other things, the input of our management and audit committee and independent third-party valuation firms that have been engaged at the direction of our board of directors to assist in the valuation of each portfolio investment without a readily available market quotation at least once during a trailing 12-month period (with certain de minimis exceptions). Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period. Additionally, the fair value of our investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that we may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we could realize significantly less than the value at which we have recorded it. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” as well as Notes 2 and 8 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information relating to our investment valuation.
Interest Rate Risk
Interest rate sensitivity refers to the change in our earnings that may result from changes in the level of interest rates. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.
In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. In addition, in a prolonged low interest rate environment, including a reduction of LIBOR to zero, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net interest income and potentially adversely affecting our operating results.
As of September 30, 2020, 83% of the investments at fair value in our portfolio bore interest at variable rates (including our investment in the SDLP Certificates which accounted for 7% of our total investments at fair value), 5% bore interest at fixed rates, 9% were non-interest earning and 3% were on non-accrual status. Additionally, excluding our investment in the SDLP Certificates, 84% of the remaining variable rate investments at fair value contained interest rate floors. The Revolving Credit Facility, the Revolving Funding Facility and the SMBC Funding Facility bear interest at variable rates with no interest rate floors. The BNP Funding Facility bears interest at variable rates using a spread over LIBOR with a LIBOR floor of 0.45%. The Unsecured Notes and the Convertible Unsecured Notes bear interest at fixed rates.
We regularly measure our exposure to interest rate risk. We assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate sensitive assets to our interest rate sensitive liabilities. Based on that review, we determine whether or not any hedging transactions are necessary to mitigate exposure to changes in interest rates.
In December 2017, in connection with $395 million of the term loan tranche of our Revolving Credit Facility, we entered into a three-year interest rate swap agreement for a total notional amount of $395 million. Under the interest rate swap agreement, we will pay a fixed interest rate of 2.06% and receive a floating rate based on the prevailing one-month LIBOR. See Note 5 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information on the Revolving Credit Facility and see Note 6 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information on the interest rate swap.
Based on our September 30, 2020 balance sheet, the following table shows the annual impact on net income of base rate changes in interest rates (considering interest rate floors for variable rate instruments) assuming no changes in our investment and borrowing structure:
| (in millions) Basis Point Change | Interest Income | Interest Expense(1) | Net Income(2) |
|---|---|---|---|
| Up 300 basis points | $355 | $44 | $311 |
| Up 200 basis points | $232 | $30 | $202 |
| Up 100 basis points | $109 | $15 | $94 |
| Down 100 basis points | $1 | $(2) | $3 |
| Down 200 basis points | $1 | $(2) | $3 |
| Down 300 basis points | $1 | $(2) | $3 |
(1) Includes the impact of the interest rate swap (discussed above) as a result of changes in interest rates.
(2) Excludes the impact of income based fees. See Note 3 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information on the income based fees.
Based on our December 31, 2019 balance sheet, the following table shows the annual impact on net income of base rate changes in interest rates (considering interest rate floors for variable rate instruments) assuming no changes in our investment and borrowing structure:
| (in millions) Basis Point Change | Interest Income | Interest Expense(1) | Net Income(2) |
|---|---|---|---|
| Up 300 basis points | $372 | $84 | $288 |
| Up 200 basis points | $248 | $56 | $192 |
| Up 100 basis points | $124 | $28 | $96 |
| Down 100 basis points | $(106) | $(28) | $(78) |
| Down 200 basis points | $(107) | $(50) | $(57) |
| Down 300 basis points | $(107) | $(50) | $(57) |
(1) Includes the impact of the interest rate swap (discussed above) as a result of changes in interest rates.
(2) Excludes the impact of income based fees. See Note 3 to our consolidated financial statements for the three and nine months ended September 30, 2020 for more information on the income based fees.
Controls and procedures
As filed, 1,702 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as that term is defined in Rules 13a‑15(e) and 15d‑15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2020. Based upon that evaluation and subject to the foregoing, our principal executive officer and principal financial officer concluded that, as of September 30, 2020, the design and operation of our disclosure controls and procedures were effective to accomplish their objectives at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rules 13a‑15(f) and 15d‑15(f) under the Exchange Act) during the quarter ended September 30, 2020 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 10,222 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the other information set forth in this report, you should carefully consider the risk factors described below and in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, which could materially affect our business, financial condition and/or operating results. The risks described below and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.
The COVID-19 pandemic has caused severe disruptions in the global economy, which has had, and may continue to have, a negative impact on our portfolio companies and our business and operations.
As of the filing date of this Quarterly Report, there is an outbreak of a highly contagious form of a novel coronavirus (“COVID-19”), which the World Health Organization has declared a global pandemic, the United States has declared a national emergency, and for the first time in its history, every state in the United States is under a federal disaster declaration. Many states, including those in which we and our portfolio companies operate, have issued orders requiring the closure of, or certain restrictions on the operation of, non-essential businesses and/or requiring residents to stay at home. The COVID-19 pandemic and preventative measures taken to contain or mitigate its spread have caused, and are continuing to cause, business shutdowns, or the re-introduction of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions and overall economic and financial market instability both globally and in the United States. Such effects will likely continue for the duration of the pandemic, which is uncertain, and for some period thereafter. While several countries, as well as certain states, counties and cities in the United States, have relaxed the public health restrictions with a view to partially or fully reopening their economies, recurring COVID-19 outbreaks have led to the re-introduction of such restrictions in certain states in the United States and globally and could continue to lead to the re-introduction of such restrictions elsewhere. Additionally, the absence or delay of viable treatment options or a vaccine could lead people to continue to self-isolate and not participate in the economy at pre-pandemic levels for a prolonged period of time. Even after the COVID-19 pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and our business and operations, as well as the business and operations of our portfolio companies, could be materially adversely affected by a prolonged recession in the U.S. and other major markets.
The COVID-19 pandemic (including the preventative measures taken in response thereto) has to date (i) created significant business disruption issues for certain of our portfolio companies, and (ii) materially and adversely impacted the value and performance of certain of our portfolio companies. The COVID-19 pandemic is having a particularly adverse impact on industries in which certain of our portfolio companies operate, including energy, hospitality, travel, retail and restaurants. Certain of our portfolio companies in other industries have also been significantly impacted. The COVID-19 pandemic is continuing as of the filing date of this Quarterly Report, and its extended duration may have further adverse impacts on our portfolio companies after September 30, 2020, including for the reasons described below. Although on March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), which contains provisions intended to mitigate the adverse economic effects of the COVID-19 pandemic, it is uncertain whether, or how much, our portfolio companies have benefited or may benefit from the CARES Act or any other subsequent legislation intended to provide financial relief or assistance. As a result of this disruption and the pressures on their liquidity, certain of our portfolio companies have been, or may continue to be, incentivized to draw on most, if not all, of the unfunded portion of any revolving or delayed draw term loans made by us, subject to availability under the terms of such loans.
The effects described above on our portfolio companies have, for certain of our portfolio companies to date, impacted their ability to make payments on their loans on a timely basis and in many cases have required us to amend certain terms, including payment terms. In addition, an extended duration of the COVID-19 pandemic may impact the ability of our portfolio companies to continue making their loan payments on a timely basis or meeting their loan covenants. The inability of portfolio companies to make timely payments or meet loan covenants may in the future require us to undertake similar amendment actions with respect to other of our investments or to restructure our investments. The amendment or restructuring of our investments may include the need for us to make additional investments in our portfolio companies (including debt or equity investments) beyond any existing commitments, exchange debt for equity, or change the payment terms of our investments to permit a portfolio company to pay a portion of its interest through payment-in-kind, which would defer the cash collection of such interest and add it to the principal balance, which would generally be due upon repayment of the outstanding principal.
The COVID-19 pandemic has adversely impacted the fair value of certain of our investments, including those reported as of September 30, 2020, and the values reported may differ materially from the values that we may ultimately realize with respect to our investments. The impact of the COVID-19 pandemic may not yet be fully reflected in the valuation of our investments as our valuations, and particularly valuations of private investments and private companies, are inherently uncertain, may fluctuate over short periods of time and are often based on estimates, comparisons and qualitative evaluations of private information that is often from a time period earlier, generally two to three months, than the quarter for which we are reporting. Additionally, we may not have yet received information or certifications from our portfolio companies that indicate the full and ongoing extent of declining performance or non-compliance with debt covenants, as applicable, as a result of the COVID-19 pandemic. As a result, our valuations, including those reported as of September 30, 2020, may not show the complete or continuing impact of the COVID-19 pandemic and the resulting measures taken in response thereto. In addition, write downs in the value of our investments have reduced, and any additional write downs may further reduce, our net asset value (and, as a result, our asset coverage calculation). Accordingly, we may continue to incur additional net unrealized losses or may incur realized losses after September 30, 2020, which could have a material adverse effect on our business, financial condition and results of operations.
The volatility and disruption to the global economy from the COVID-19 pandemic has affected, and is expected to continue to affect, the pace of our investment activity and the size of our portfolio, which may have a material adverse impact on our results of operations, including our total investment income. Such volatility and disruption have also led to the increased credit spreads in the private debt capital markets.
Despite actions of the U.S. federal government and foreign governments, the uncertainty surrounding the COVID-19 pandemic and other factors has contributed to significant volatility and declines in the global public equity markets and global debt capital markets, including the market price of shares of our common stock and the trading prices of our issued debt securities. Shares of our common stock are trading below our net asset value as of the filing date of this Quarterly Report. Market conditions may make it difficult for us to raise equity capital because, subject to some limited exceptions, as a BDC, we are generally not able to issue additional shares of our common stock at a price less than net asset value without first obtaining approval for such issuance from our stockholders and our independent directors. Pursuant to approval granted at a special meeting of stockholders, held on August 13, 2020, we are permitted to sell or otherwise issue shares of our common stock at a price below net asset value, subject to certain limitations and determinations that must be made by our board of directors. Such stockholder approval expires on August 31, 2021. Moreover, these market conditions may make it difficult to access or obtain new indebtedness with similar terms to our existing indebtedness or otherwise have a negative effect on our cost of capital. See “Risk Factors-Risks Relating to Our Business-The capital markets may experience periods of disruption and instability. Such market conditions may materially and adversely affect debt and equity capital markets, which may have a negative impact on our business and operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019.
In response to the COVID-19 pandemic, Ares Management Corporation instituted a work from home policy until it is deemed safe to return to the office. Such a policy of an extended period of remote working by our investment adviser and/or its affiliate’s employees could strain our technology resources and introduce operational risks, including heightened cybersecurity risk. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts that seek to exploit the COVID-19 pandemic.
Source: SEC EDGAR, the filing index for accession 0001287750-20-000038. Last ingested by Listed: Oct 29, 2026, 19:05 ET. Listed shows no prices and gives no investment advice.